What is Biomarker Testing and Why is it Important in Oncology?</span> - oncomine.com/blog/what-is-b…

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >What is Biomarker Testing and Why is it Important in Oncology?</span> - oncomine.com/blog/what-is-b…

A tweetorial on our study (gastrojournal.org/article/S0016-…). But, first a case: Young female w/ a 1.9 cm incidental pancreatic cyst. No concerning features, but KRAS, TP53 and SMAD4 mutations on molecular testing. Surgical resection: #IPMN w/ a small #PancreaticCancer. #Pathology #GIPath

Paul Hofman on implementing #liquidbiopsy in #lungcancer Fascinating talk on how to test relevant #biomarkers to best serve our patients

CONGRESS | #ASH22 Richard Little, National Cancer Institute, describes the MyeloMATCH precision medicine trial, spanning across the National Clinical Trials Network. Patients will be screened and assigned appropriate treatment trials, with data integrated across the initiative. #leusm #mdssm

So proud for Thermo Fisher to be partnering with CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients curesearch.org/curesearch-to-… via CureSearch

As #CRCAwarenessMonth comes to an end, we are excited to share that we are collaborating with Colorectal Cancer Canada & Thermo Fisher to offer a quality improvement RFP focusing on improving molecular testing turnaround times for patients with #CRC and other tumour types.

Defeating cancer requires collaboration across the health & scientific ecosystem. Every day, we stand behind scientists & healthcare professionals working to understand what causes cancer, and how to better diagnose and treat it. Here are their stories: bit.ly/3magfP6

Fourth-year student Caleb Fronk took first place honors at the TMS 152nd Annual Meeting and Exhibition! 🎉 Learn about Fronk’s award-winning project focused on an aluminum fabricated via additive manufacturing ➡️ bit.ly/42V7w41

More data showing the importance of *waiting* for NGS results before starting NSCLC therapy whenever possible! Retrospective analysis JCO Oncology Practice show that when treatment of driver+ NSCLC before biomarker results is associated with inferior survival. ascopubs.org/doi/abs/10.120…

In our latest Ask a Cancer Researcher video, Dr. Melanie Spears, Co-Director of Diagnostic Development, explains how the risk of #breastcancer recurrence can be predicted and discusses new, more accurate tests that her team is creating to help guide treatment.

Thermo Fisher Scientific, Boehringer Ingelheim Partner on Companion Dx for Lung Cancer. The firms will develop multiple NGS-based companion diagnostic tests based on the Oncomine Dx Express Test and Oncomine Dx Target Test. ow.ly/wLT0104Yjb6

#Biomarker testing is not standard in #lungcancer care, causing missed opportunities for patients in their search for an ideal treatment. #Healthcareproviders: let's work to ensure this is a step in every #NSCLC journey. Learn more on #NoOneMissed: no1missed.org/47rgXtt #LCSM

Watch a clip from our recent webinar to hear Jennifer Carlisle highlight the importance of #biomarker testing for personalized #NSCLC care. Learn more about #biomarkertesting on the #NoOneMissed site: no1missed.org/4aiPRa8 #LCSM

Do you want your patients to know more about how #biomarkertesting is impacting their treatment & #clinicaltrial options? The new Biomarker Testing Discussion Guide, created w/ #patients & #providers, can help them understand their results: lungevity.org/biomarkerdiscu…

So exciting to hear ⁦Christian Rolfo⁩ speak about the potential for liquid biopsy in early stage NSCLC #DCLung24 ⁦Stephen V Liu, MD⁩ ⁦Liquid Biopsy⁩ ⁦David Gandara⁩

🫁 #Lungcancer is the leading cause of cancer deaths in America, but a low-dose CT scan can help catch it early—when it’s most treatable. ➡️Take the next step in protecting yourself or a loved one with details on how to schedule a lung screening today: baptisthealth.net/lungscreening

Watch our just-added recorded webinar about molecular testing for determining treatment strategies for acute leukemia. 📼On-demand video: players.brightcove.net/3663210762001/…

.Christian Rolfo dreamed of helping people in big ways. That dream took him around the globe - and helped him developed an international reputation for his pioneering work in liquid biopsy and other medical innovations. health.osu.edu/health/cancer/…

FDA approval alert! On July 2, 2025 the US FDA granted accelerated approval to sunvozertinib for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations. Learn more here: egfr.lungevity.org/new-treatment-…